急性深静脉血栓药物机械溶栓后急性肾损伤的危险因素
本研究回顾性分析2007至2018年137例因急性深静脉血栓接受药物机械溶栓(PMT)的患者,21.9%发生围术期急性肾损伤(AKI),其中1例需血液透析;双侧DVT、单次PMT和女性是AKI的独立预测因素,少数患者进展为慢性肾功能不全。
要点
- PMT治疗急性DVT后约21.9%发生围术期AKI,需监测肾功能。
- 双侧DVT、单次PMT和女性是AKI的独立预测因素。
- 对双侧广泛DVT患者,PMT前延长溶栓药物预灌注可能更优。
核心结论
- PMT治疗急性DVT存在AKI风险,小部分患者进展为慢性肾功能不全。
研究设计与样本
- 回顾性病历回顾,纳入2007至2018年接受PMT的急性DVT患者137例,平均年龄47±16.6岁,男性49.6%。
主要发现
- 137例中30例(21.9%)发生围术期AKI,1例需围术期血液透析。
- AKI组术前冠心病(23.1% vs 4.7%;P=.002)、糖尿病(19.2% vs 6.6%;P=.045)、血脂异常(42.3% vs 17.9%;P=.008)和高血压(53.6% vs 29.3%;P=.018)比例显著更高。
- 两组术前肌酐(0.99 vs 0.92 mg/dL;P=.65)和GFR(96.9 vs 91.8 mL/min;P=.52)无显著差异。
- 多因素分析显示双侧DVT(OR 4.35;95%CI 1.47-12.86;P=.008)、单次PMT(OR 3.05;95%CI 1.02-9.11;P=.046)和女性(OR 2.85;95%CI 1.01-8.04;P=.048)是AKI的显著预测因素。
- 30例AKI患者中,出院时10例、首次随访15例、后续随访25例肾功能正常;5例(3.6%)进展为中度(GFR<60 mL/min)或重度(GFR<30 mL/min)肾功能不全,1例需长期血液透析。
临床怎么用
- PMT围术期应监测肾功能,尤其对双侧DVT、单次PMT和女性患者。
- 对双侧广泛DVT患者,可考虑PMT前延长溶栓药物预灌注以降低AKI风险。
局限性
- 回顾性单中心研究,样本量有限,结果需外推验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pharmacomechanical thrombolysis (PMT) is an established treatment for selected patients with acute deep vein thrombosis (DVT). Despite significant clinical success, hemolysis can lead to acute kidney injury (AKI) with unknown longer term implications. Our aim was to characterize the rate of AKI after PMT and identify those patients at the greatest risk. METHODS: A retrospective medical record review of patients with acute DVT who had undergone PMT in our institution from 2007 to 2018 was performed. The baseline demographics, comorbidities, preoperative clinical characteristics, procedural details, postoperative hospital course, and follow-up data were reviewed. The primary outcome was postoperative AKI (≥1.5 times preoperative creatinine), and longer term renal impairment. Logistic regression modeling was used to identify associated factors. RESULTS: A total of 137 patients (mean age, 47 ± 16.6 years; 49.6% male) who had undergone PMT for treatment of acute DVT were identified (85.4% AngioJet system; Boston Scientific Corp, Marlborough, Mass). Of the 137 patients, 30 (21.9%) had developed AKI in the periprocedural period, 1 of whom had required hemodialysis in the perioperative period. The patients who had developed AKI had had significantly greater rates of preoperative coronary artery disease (23.1% vs 4.7%; P = .002), diabetes mellitus (19.2% vs 6.6%; P = .045), dyslipidemia (42.3% vs 17.9%; P = .008), and hypertension (53.6% vs 29.3%; P = .018). No significant difference was found in preoperative creatinine (0.99 vs 0.92 mg/dL; P = .65) or glomerular filtration rate (GFR; 96.9 vs 91.8 mL/min; P = .52) between the two groups. Multivariate analysis demonstrated bilateral DVT (odds ratio [OR], 4.35; 95% confidence interval [CI], 1.47-12.86; P = .008), single-session PMT (OR, 3.05; 95% CI, 1.02-9.11; P = .046), and female sex (OR, 2.85; 95% CI, 1.01-8.04; P = .048) were significant predictors of AKI. Of the 30 patients, 10 had had normal renal function at discharge and 15 and 25 patients had had normal renal function at the first and subsequent clinical follow-up visits, respectively. The remaining five patients (3.6%) had progressed to moderate (GFR, <60 mL/min) or severe (GFR, <30 mL/min) renal insufficiency, with one requiring long-term hemodialysis. CONCLUSIONS: The use of PMT for treatment of acute DVT conferred a risk of AKI that will progress to chronic renal failure in a small fraction of affected patients. Patients with bilateral extensive DVTs have a greater risk of AKI; thus, longer priming with a thrombolytic drip before PMT should be preferred for this population.
引用
- Salem KM, Saadeddin Z, Go C, et al. Risk factors for acute kidney injury after pharmacomechanical thrombolysis for acute deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33186753. doi:10.1016/j.jvsv.2020.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。